Evidence map›Paper›PMID 35801252›Full record

ArticleFrontiers in public health2022

Global, Regional, and National Burden of Cancer in Children Younger Than 5 Years, 1990-2019: Analysis of the Global Burden of Disease Study 2019.

Hui-Ming Ren, Min-Qi Liao, Si-Xian Tan, Chen Cheng, Sui Zhu, Lu Zheng, Jun-Rong Ma, Ying-Jun Mu, Wan-Lin Li, Shi-Wen Zhang and 12 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Hui-Ming RenDepartment of Rehabilitation Medicine, Hwa Mei Hospital, University of the Chinese Academy of Sciences, Ningbo, China.
Min-Qi LiaoDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Si-Xian TanDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Chen ChengDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Sui ZhuDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Lu ZhengDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Jun-Rong MaDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Ying-Jun MuDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Wan-Lin LiDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Shi-Wen ZhangDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Rui-Qing OuYangDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Shu-Na LiDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Yun-Feng CuiDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Xing-Yao KeDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Ze-Yan LuoDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Peng XiongDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Jun LiuDepartment of Preventive Medicine Laboratory, School of Public Health, Zunyi Medical University, Zunyi, China.
Li-Ping LiGuangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment, Cancer Hospital of Shantou University Medical College, Shantou, China.
Xiao-Feng LiangDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Fang-Fang ZengDepartment of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China.
Xue-Fen SuGuangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment, Cancer Hospital of Shantou University Medical College, Shantou, China.
Li-Yuan HanHwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To quantify the burden and variation trends of cancers in children under 5 years at the global, regional, and national levels from 1990 to 2019. Methods: Epidemiological data for children under 5 years who were diagnosed with any one childhood cancer were obtained from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) from 1990 to 2019. The outcomes were the absolute numbers and rates of incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) for different types of cancer. Results: In 2019, 8,774,979.1 incident cases (95% uncertainty interval [UI]: 6,243,599.2 to11,737,568.5) and 8,956,583.8 (6,446,323.9 to 12,364,520.8) prevalent cases of cancer in children under 5 years were identified worldwide; these cancers resulted in 44,451.6 (36,198.7 to 53,905.9) deaths and 3,918,014.8 (3,196,454.9 to 4,751,304.2) DALYs. From 1990 to 2019, although the numbers of incident and prevalent cases only decreased by -4.6% (-7.0 to -2.2) and -8.3% (-12.6 to -3.4), respectively, the numbers of deaths and DALYs clearly declined by -47.8% (-60.7 to -26.4) and -47.7% (-60.7 to -26.2), respectively. In 2019, the middle sociodemographic index (SDI) regions had the highest incidence and prevalence, whereas the low SDI regions had the most mortality and DALYs. Although all of the SDI regions displayed a steady drop in deaths and DALYs between 1990 and 2019, the low-middle and low SDI regions showed increasing trends of incidence and prevalence. Leukemia remained the most common cancer globally in 2019. From 1990 to 2019, the burdens of leukemia, liver cancer, and Hodgkin's lymphoma declined, whereas the incidence and prevalence of other cancers grew, particularly testicular cancer. Conclusions: The global childhood cancer burden in young children has been steadily decreasing over the past three decades. However, the burdens and other characteristics have varied across different regions and types of cancers. This highlights the need to reorient current treatment strategies and establish effective prevention methods to reduce the global burden of childhood cancer.

Indexed as

LeukemiaTesticular NeoplasmsChildChild, PreschoolGlobal Burden of DiseaseHumansIncidenceMaleQuality-Adjusted Life Yearschildhood cancerglobal burden of diseaseglobal healthpublic healthsecular trends

Identifiers

PMID35801252
PMCPMC9255714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.